Mary Ellen Martin

2.4k total citations · 1 hit paper
54 papers, 1.7k citations indexed

About

Mary Ellen Martin is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Mary Ellen Martin has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 15 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Mary Ellen Martin's work include Acute Myeloid Leukemia Research (18 papers), Hematopoietic Stem Cell Transplantation (15 papers) and Neutropenia and Cancer Infections (8 papers). Mary Ellen Martin is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Hematopoietic Stem Cell Transplantation (15 papers) and Neutropenia and Cancer Infections (8 papers). Mary Ellen Martin collaborates with scholars based in United States, Canada and Germany. Mary Ellen Martin's co-authors include Thomas A. Milne, Jay L. Hess, Hugh W. Brock, Denise Gibbs, C. David Allis, Scott Briggs, Robert K. Slany, Yali Dou, Robert G. Roeder and J. Stephen Dumler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Molecular Cell.

In The Last Decade

Mary Ellen Martin

50 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters

2002 833 citations Thomas A. Milne, Scott Briggs et al. Molecular Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Ellen Martin United States	14	1.2k	641	153	145	132	54	1.7k
Takahiro Karasuno Japan	16	347 0.3×	349 0.5×	83 0.5×	134 0.9×	165 1.3×	50	775
Thierry Peyrard France	19	302 0.2×	745 1.2×	98 0.6×	112 0.8×	156 1.2×	84	1.4k
Narcis I. Popescu United States	15	554 0.5×	239 0.4×	75 0.5×	53 0.4×	600 4.5×	27	1.3k
Andrea D’Osualdo Italy	13	1.0k 0.9×	231 0.4×	72 0.5×	79 0.5×	666 5.0×	21	1.3k
Hilde Schjerven United States	20	536 0.4×	213 0.3×	239 1.6×	183 1.3×	672 5.1×	29	1.4k
Nawarat Wara-aswapati Thailand	17	442 0.4×	151 0.2×	115 0.8×	90 0.6×	307 2.3×	25	1.1k
Deepti Verma Sweden	17	916 0.8×	180 0.3×	36 0.2×	100 0.7×	762 5.8×	29	1.3k
Emanuela Rosati Italy	18	409 0.3×	115 0.2×	217 1.4×	149 1.0×	436 3.3×	45	1.2k
Ian T. Magrath United States	7	220 0.2×	291 0.5×	50 0.3×	269 1.9×	584 4.4×	9	1.2k
Martin Vokurka Czechia	18	258 0.2×	428 0.7×	18 0.1×	78 0.5×	99 0.8×	48	1.2k

Countries citing papers authored by Mary Ellen Martin

Since Specialization

Citations

This map shows the geographic impact of Mary Ellen Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ellen Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ellen Martin more than expected).

Fields of papers citing papers by Mary Ellen Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ellen Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ellen Martin. The network helps show where Mary Ellen Martin may publish in the future.

Co-authorship network of co-authors of Mary Ellen Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ellen Martin. A scholar is included among the top collaborators of Mary Ellen Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ellen Martin. Mary Ellen Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gimotty, Phyllis A., Andrew Matthews, Ronac Mamtani, et al.. (2025). Evolving racial/ethnic disparities in AML survival in the novel therapy era. Blood Advances. 9(3). 533–544. 1 indexed citations

Loren, Alison W., Elizabeth O. Hexner, Mary Ellen Martin, et al.. (2022). Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies. Transplantation and Cellular Therapy. 29(2). 113–118. 2 indexed citations

Matthews, Andrew, Alexander E. Perl, Selina M. Luger, et al.. (2022). Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. Blood Advances. 6(13). 3997–4005. 53 indexed citations

Freyer, Craig W., Alison W. Loren, Noelle V. Frey, et al.. (2022). Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia. Leukemia & lymphoma. 63(7). 1645–1650. 9 indexed citations

Freyer, Craig W., Daria V. Babushok, Noelle V. Frey, et al.. (2022). Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis. Transplantation and Cellular Therapy. 28(9). 590–596. 6 indexed citations

Freyer, Craig W., Shannon Gier, Alex Ganetsky, et al.. (2021). Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay. Transplantation and Cellular Therapy. 27(5). 431.e1–431.e8. 2 indexed citations

Freyer, Craig W., Michael G. Fradley, Joseph R. Carver, et al.. (2021). Characterization of Pericarditis following Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 27(11). 934.e1–934.e6. 2 indexed citations

Freyer, Craig W., Alex Ganetsky, Mitchell E. Hughes, et al.. (2020). Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation. Leukemia & lymphoma. 61(9). 2200–2207. 5 indexed citations

Freyer, Craig W., Alex Ganetsky, Colleen Timlin, et al.. (2019). Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment and Length of Hospitalization in Myeloablative Allogeneic Hematopoietic Transplantation. Biology of Blood and Marrow Transplantation. 25(3). S283–S283. 2 indexed citations

10.

Ganetsky, Alex, Noelle V. Frey, Elizabeth O. Hexner, et al.. (2018). Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract. Bone Marrow Transplantation. 54(2). 212–217. 33 indexed citations

11.

Freyer, Craig W., Alex Ganetsky, Mitchell E. Hughes, et al.. (2018). Venous Thromboembolism Following Pegaspargase in Adults Receiving Antithrombin Supplementation: A Single Center Characterization of Risk Factors and an Assessment of Supplementation Practice. Blood. 132(Supplement 1). 4023–4023. 2 indexed citations

12.

Wang, Congli, et al.. (2014). A rare case of subcutaneous Sweet’s syndrome in a patient with chronic myelogenous leukemia: a case report and review of the literature. Journal of Hematopathology. 7(2). 79–83.

13.

Paralkar, Vikram R., Sunita D. Nasta, Jacqueline Smith, et al.. (2011). Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas. Bone Marrow Transplantation. 47(7). 940–945. 21 indexed citations

14.

Milne, Thomas A., Mary Ellen Martin, Hugh W. Brock, Robert K. Slany, & Jay L. Hess. (2005). Leukemogenic MLL Fusion Proteins Bind across a Broad Region of the Hox a9 Locus, Promoting Transcription and Multiple Histone Modifications. Cancer Research. 65(24). 11367–11374. 141 indexed citations

15.

Martin, Mary Ellen, Thomas A. Milne, Sébastien Bloyer, et al.. (2003). Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell. 4(3). 197–207. 128 indexed citations

16.

Milne, Thomas A., Scott Briggs, Hugh W. Brock, et al.. (2002). MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters. Molecular Cell. 10(5). 1107–1117. 833 indexed citations breakdown →

17.

Bachmann, Kenneth, Timothy J. Sullivan, Laurie S. Mauro, et al.. (1992). Comparative Investigation of the Influence of Nizatidine, Ranitidine, and Cimetidine on the Steady‐State Pharmacokinetics of Theophylline in COPD Patients. The Journal of Clinical Pharmacology. 32(5). 476–482. 7 indexed citations

18.

Bachmann, K, et al.. (1990). The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism. Xenobiotica. 20(5). 537–547. 8 indexed citations

19.

Bachmann, K, et al.. (1988). Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients. Antimicrobial Agents and Chemotherapy. 32(5). 730–735. 21 indexed citations

20.

Bachmann, Kenneth, Jules I. Schwartz, Luis Jáuregui, Timothy J. Sullivan, & Mary Ellen Martin. (1987). Use of Three Probes to Assess the Influence of Sex on Hepatic Drug Metabolism. Pharmacology. 35(2). 88–93. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact